Merck KGaA's chief executive Belén Garijo will end her time at the helm of the company next April, five years after taking ...

Investors in Verona – a specialist in respiratory medicines – overwhelmingly gave their blessing to MSD's $107-per-share ...

Under the Inflation Reduction Act of 2022, the Department of Health and Human Services (HHS), which oversees Medicare, can ...

US biotechs Acadia Pharma and Harmony Biosciences have both suffered setbacks in phase 3 trials of drugs for rare diseases – ...

The Moderna Innovation and Technology Centre (MITC) in Harwell is the flagship part of a 10-year, £1 billion investment in ...

Earlier this year, PTC Therapeutics and Novartis' experimental therapy for Huntington's, mRNA splicing modifier PTC518 ...

In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with healthcare innovation ...

Iberdomide, which is being positioned as a successor to Revlimid, will continue in EXCALIBER-RRMM as the study progresses to ...

A new UK start-up called Dalton Tx emerged from stealth with seed financing of £4 million ($5.4 million) and a mission to ...

The UK’s National Cancer Plan rightly puts patients at the heart of its ambitions, with a focus on prevention, early ...

According to a head-to-head trial called DEVOTE, which underpins the application, the high-dose of nusinersen slowed ...

The Houston facility has been selected as one that will make orforglipron, Lilly's new oral GLP-1 agonist for weight-loss, ...